Hedge Fund - Soleus Capital
Iovance Biotherapeutics Inc. (IOVA)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $25,924,050 | 1.87% | 7,785,000 | $5.16 |
2 | 2024 - Q4 (2024-12-31) | $48,544,000 | 3.05% | 6,560,000 | $9.27 |
3 | 2024 - Q3 (2024-09-30) | $80,082,615 | 6.2% | 8,528,500 | $9.47 |
4 | 2024 - Q2 (2024-06-30) | $60,534,960 | 5.33% | 7,548,000 | $10.72 |
5 | 2024 - Q1 (2024-03-31) | $51,944,100 | 3.85% | 3,505,000 | $11.64 |
6 | 2023 - Q4 (2023-12-31) | $4,512,150 | 0.5% | 555,000 | $5.23 |
7 | 2023 - Q3 (2023-09-30) | $5,640,985 | 0.52% | 1,239,777 | $6.53 |
8 | 2023 - Q2 (2023-06-30) | $8,728,030 | 0.97% | 1,239,777 | $7.16 |
9 | 2023 - Q1 (2023-03-31) | $8,858,137 | 0.91% | 1,449,777 | $6.90 |
10 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $7.81 |
11 | 2022 - Q3 (2022-09-30) | $9,821,000 | 1.33% | 1,025,200 | $11.53 |
12 | 2022 - Q2 (2022-06-30) | $7,944,000 | 1.23% | 719,600 | $13.10 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:100.0000 on 2013-09-26
-
23999.0000:1000.0000 on 2010-05-26